Semaglutide Injection 1.7 mg is a prescription GLP-1 receptor agonist formulation of semaglutide. The supplied product image shows a 3 mL pre-filled pen described as a once-weekly injectable presentation. Product strength, brand, registration status and packaging should always be verified against the applicable manufacturer documentation and destination-country regulatory requirements.
Semaglutide medicines are used for different approved indications depending on the specific product and jurisdiction. For example, FDA-approved semaglutide products include formulations used for type 2 diabetes and chronic weight management under specified conditions.
Product Details
| Product Information | Details |
|---|---|
| Generic Name | Semaglutide |
| Dosage Form | Injection |
| Strength | 1.7 mg |
| Presentation | 3 mL pre-filled pen, as shown |
| Administration | Subcutaneous |
| Frequency | Once weekly for applicable approved presentations |
| Therapeutic Category | GLP-1 receptor agonist |
| Category | Diabetes & Weight Management / Specialty Pharmaceuticals |
| Prescription Status | Prescription medicine; requirements vary by country |
Uses of Semaglutide
Depending on the specific approved product, semaglutide may be prescribed for:
- Type 2 diabetes management
- Chronic weight management in eligible patients
- Certain cardiovascular-risk reduction indications
- Other approved indications in particular jurisdictions
The exact indication depends on the product's regulatory approval, strength and labeling.
Important Safety Information
Semaglutide should be used only under appropriate medical supervision. Official prescribing information includes important warnings and precautions, including risks involving gastrointestinal adverse reactions, pancreatitis, gallbladder disease, hypoglycemia in certain combinations, kidney injury related to volume depletion, and hypersensitivity reactions.
The FDA prescribing information also contains a boxed warning concerning thyroid C-cell tumors based on findings in rodents and lists contraindications including a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Patients should not start, stop or change semaglutide treatment without advice from a qualified healthcare professional.
International Medicine Export
MEDINDIA EXPORT / BizHQ supports international pharmaceutical trade inquiries for eligible markets, subject to applicable prescription, import, customs, product-registration and pharmaceutical regulations.
Target Export Markets
- 🇺🇸 USA
- 🇬🇧 UK
- 🇸🇬 Singapore
- 🇹🇭 Thailand
- 🇦🇪 UAE
- 🇦🇺 Australia
- 🇲🇾 Malaysia
- 🇳🇿 New Zealand
Availability and importability of prescription medicines can differ substantially between these markets. Buyers and importers should confirm local regulatory requirements before placing an order.
Why Choose MEDINDIA EXPORT?
- International pharmaceutical sourcing
- Product-focused export assistance
- Support for medicine procurement inquiries
- Documentation and shipping coordination subject to destination requirements
- Worldwide export support for eligible pharmaceutical products
- Professional communication for pharmacies, distributors, healthcare businesses and authorized buyers
Trading FAQs – Semaglutide Injection 1.7 mg
Q1. What is Semaglutide Injection 1.7 mg?
Semaglutide Injection 1.7 mg is an injectable formulation containing semaglutide, a GLP-1 receptor agonist.
Q2. Is semaglutide a prescription medicine?
Yes. Semaglutide products are prescription medicines in many markets, and regulatory requirements differ by country. In the United States, FDA-approved semaglutide products are available by prescription.
Q3. How is semaglutide administered?
Approved injectable semaglutide products are administered subcutaneously according to their prescribing information. The appropriate dose and schedule must be determined by a healthcare professional.
Q4. Can Semaglutide Injection be exported internationally?
International shipment depends on the destination country's pharmaceutical import laws, product registration, prescription requirements and customs rules. MEDINDIA EXPORT handles inquiries subject to applicable regulations.
Q5. Can I order semaglutide without a prescription?
Prescription requirements depend on the destination country. Buyers should comply with the laws and prescription requirements applicable to their location.
Q6. Is Semaglutide Injection used for weight management?
Certain semaglutide products are approved for chronic weight management in specified patient populations. The indication depends on the particular product and country.
Q7. Can semaglutide be used for diabetes?
Certain approved semaglutide products are indicated for type 2 diabetes management. The approved indication depends on the specific product.
Q8. Is Semaglutide Injection suitable for everyone?
No. Medical eligibility, contraindications, drug interactions and other factors must be evaluated by a qualified healthcare professional.
Q9. How should semaglutide be stored?
Storage requirements vary according to the exact product and manufacturer labeling. Buyers should follow the product's official storage instructions and applicable cold-chain requirements.
Q10. Do you provide international shipping?
International shipping can be arranged for eligible pharmaceutical orders, subject to destination-country regulations, documentation and carrier requirements.
Request a Semaglutide Product Inquiry
For product availability, quotation, export documentation and destination-specific requirements, contact:
🌐 Website: www.medicineindiaexport.com
📧 Email: sales.medindiaexport@gmail.com
📱 WhatsApp: +91 7218129896
MEDINDIA EXPORT – International Medicine Export & Pharmaceutical Sourcing
